Multiple Sclerosis Clinical Quiz
History
- 30-year-old woman.
- Headache for 2 days.
- Dizziness.
- Weakness involving all four limbs.
- Previous similar neurological episode one year earlier.
- History of transient blurring of vision six months ago that improved after treatment.
- Relapsing neurological symptoms affecting different anatomical sites.
Physical Examination
- Assess visual acuity and color vision.
- Check for relative afferent pupillary defect.
- Fundoscopy for optic atrophy.
- Upper motor neuron signs.
- Hyperreflexia.
- Extensor plantar responses.
- Spastic quadriparesis.
- Sensory examination.
- Cerebellar signs.
- Gait assessment.
Investigations
- MRI Brain (T1 Axial): Multiple rounded periventricular lesions with variable ring enhancement.
- MRI Cervical Spine (T2): Hyperintense cervical spinal cord lesion.
- CSF oligoclonal bands.
- Visual evoked potential showing delayed conduction.
- Serum Aquaporin-4 antibody to exclude Neuromyelitis Optica.
- MOG antibody if clinically indicated.
MCQ 1
Most likely diagnosis?
Click to Reveal Answer
MCQ 2
Immediate management of acute relapse?
Click to Reveal Answer
MCQ 3
Disease-modifying therapy to prevent future attacks?
Click to Reveal Answer
MCQ 4
Expected eye finding?
Click to Reveal Answer
- B. Optic atrophy with RAPD (following optic neuritis).
- D. Internuclear ophthalmoplegia with nystagmus is also a classic ocular manifestation of Multiple Sclerosis.
Brief Case Summary
A young woman has recurrent neurological deficits separated in time and affecting different areas of the central nervous system. MRI demonstrates multiple periventricular lesions with cervical cord involvement, suggesting a chronic inflammatory demyelinating disease.
Answer Explanation
The patient demonstrates the classic features of relapsing-remitting Multiple Sclerosis (RRMS). Previous optic neuritis, recurrent neurological deficits, multifocal MRI lesions and dissemination in time strongly support the diagnosis.
Acute relapses are treated with high-dose corticosteroids, while long-term disease-modifying therapy reduces relapse frequency and disability progression.
Why Not the Other Options?
| Option | Reason |
|---|---|
| Neuromyelitis Optica | Usually presents with longitudinally extensive transverse myelitis and Aquaporin-4 antibody positivity rather than classic periventricular MS plaques. |
| CNS Vasculitis | Usually causes multifocal ischemic lesions and systemic inflammatory features rather than typical demyelinating plaques. |
| Cerebral Toxoplasmosis | Occurs mainly in immunocompromised patients and presents with fever, altered mental status, and multiple abscesses. |
| Plasmapheresis | Reserved for severe steroid-resistant relapses. |
| IVIG | Not first-line treatment for acute MS relapse. |
Five Brief Clinical Case Scenarios
| SL | Clinical Scenario |
|---|---|
| 1 | A 24-year-old woman develops painful unilateral visual loss that improves after intravenous corticosteroids. |
| 2 | A 29-year-old woman experiences numbness of one leg followed by complete recovery. Eight months later she develops diplopia. |
| 3 | A 35-year-old man presents with gait imbalance, intention tremor and scanning speech. MRI shows multiple cerebellar plaques. |
| 4 | A 31-year-old woman develops urinary urgency, spastic paraparesis and sensory loss. MRI reveals cervical spinal cord demyelinating lesions. |
| 5 | A 38-year-old woman reports recurrent neurological symptoms separated by several months affecting different CNS regions with MRI evidence of dissemination in time and space. |
Simplified Pathophysiology
- Autoimmune attack against central nervous system myelin.
- Activated T cells cross the blood-brain barrier.
- Inflammation causes demyelination.
- Axonal injury develops with repeated attacks.
- Demyelination slows nerve conduction.
- Plaques form in the brain, optic nerves and spinal cord.
- Repeated inflammation eventually causes permanent neurological disability.
Physical Examination Pearls
- Look carefully for optic neuritis.
- Check visual acuity and colour vision.
- Test for relative afferent pupillary defect.
- Examine eye movements for internuclear ophthalmoplegia.
- Hyperreflexia with extensor plantar responses suggests upper motor neuron involvement.
- Spasticity is common.
- Cerebellar dysfunction causes intention tremor and ataxia.
- Sensory level may indicate spinal cord involvement.
- Assess gait carefully.
- Evaluate bladder dysfunction.
Typical Investigation Findings
| Investigation | Typical Finding |
|---|---|
| MRI Brain | Periventricular, juxtacortical, infratentorial and corpus callosum plaques. |
| MRI Spine | Short segment cervical cord lesions. |
| Gadolinium MRI | Enhancing active plaques and non-enhancing chronic plaques. |
| CSF | Oligoclonal IgG bands. |
| IgG Index | Raised. |
| Visual Evoked Potential | Delayed P100 latency. |
| Aquaporin-4 Antibody | Usually negative. |
Complications
- Permanent disability.
- Progressive gait impairment.
- Visual impairment.
- Chronic neuropathic pain.
- Spasticity.
- Neurogenic bladder.
- Recurrent urinary tract infections.
- Depression.
- Cognitive impairment.
- Falls and fractures.
- Fatigue.
- Sexual dysfunction.
Management
Acute Relapse
- High-dose intravenous methylprednisolone for 3–5 days.
- Equivalent high-dose oral methylprednisolone when appropriate.
- Plasma exchange for steroid-resistant severe relapse.
Disease-Modifying Therapy
- Interferon-beta.
- Glatiramer acetate.
- Dimethyl fumarate.
- Teriflunomide.
- Fingolimod.
- Siponimod.
- Natalizumab.
- Ocrelizumab.
- Alemtuzumab.
Supportive Care
- Physiotherapy.
- Occupational therapy.
- Speech therapy if required.
- Bladder management.
- Vitamin D optimization.
- Psychological support.
- Regular exercise.
- Smoking cessation.
Differential Diagnosis
- Neuromyelitis Optica Spectrum Disorder.
- MOG antibody disease.
- Acute disseminated encephalomyelitis.
- CNS vasculitis.
- Neurosarcoidosis.
- Vitamin B12 deficiency.
- Subacute combined degeneration.
- Progressive multifocal leukoencephalopathy.
- Lyme disease.
- HIV-associated CNS disease.
- Systemic lupus erythematosus.
- Cerebral small vessel disease.
Clinical Pitfalls
- Do not diagnose MS after a single neurological episode without appropriate evidence.
- Always exclude infections before immunosuppressive therapy.
- Rule out Neuromyelitis Optica with Aquaporin-4 antibody testing when indicated.
- Spinal cord lesions longer than three vertebral segments suggest NMOSD.
- Avoid unnecessary long-term corticosteroid therapy.
- Disease-modifying therapy should begin early in suitable patients.
- Do not ignore cognitive symptoms.
- Screen for depression and fatigue routinely.
Clinical Pearls
- Multiple sclerosis commonly affects young women.
- Optic neuritis is often the first presentation.
- Symptoms are separated in both time and anatomical location.
- Periventricular plaques are characteristic on MRI.
- CSF oligoclonal bands support the diagnosis.
- High-dose corticosteroids shorten relapse duration.
- Disease-modifying therapy reduces relapse frequency.
- Early treatment improves long-term outcomes.
- Exercise improves fatigue and mobility.
- Smoking worsens disease progression.
Monitoring & Follow-up
- Neurological examination at every follow-up visit.
- Annual MRI brain or as clinically indicated.
- Monitor relapse frequency.
- Assess disability using EDSS.
- Monitor adverse effects of disease-modifying therapy.
- Regular ophthalmology review.
- Assess bladder and bowel symptoms.
- Evaluate cognitive function.
- Monitor liver function where appropriate.
- Screen for infections before biologic therapy.
Prognosis
- Most patients initially have relapsing-remitting disease.
- Early diagnosis improves long-term neurological outcome.
- Modern disease-modifying therapies significantly reduce relapse rates.
- Some patients eventually develop secondary progressive disease.
- Visual recovery after optic neuritis is usually good.
- Long-term disability varies considerably between individuals.
- Regular follow-up and adherence to treatment improve quality of life.
Frequently Asked Questions (FAQ)
1. What is Multiple Sclerosis?
Multiple sclerosis is a chronic autoimmune demyelinating disease of the central nervous system affecting the brain, spinal cord, and optic nerves.
2. Who is commonly affected?
Young adults, especially women between 20 and 40 years of age.
3. What causes Multiple Sclerosis?
It results from immune-mediated destruction of myelin in genetically susceptible individuals exposed to environmental triggers.
4. What is the most common initial symptom?
Optic neuritis, sensory symptoms, or limb weakness are common first presentations.
5. Why is MRI important?
MRI demonstrates characteristic demyelinating plaques and helps establish dissemination in time and space.
6. What are oligoclonal bands?
They are immunoglobulin bands detected in cerebrospinal fluid that support the diagnosis of Multiple Sclerosis.
7. How are acute relapses treated?
High-dose intravenous or oral methylprednisolone for 3–5 days is first-line treatment.
8. When is plasma exchange used?
It is reserved for severe relapses that do not respond to corticosteroids.
9. What are disease-modifying therapies?
They reduce relapse frequency, MRI activity, and long-term disability progression.
10. Can Multiple Sclerosis be cured?
No. Current treatment controls disease activity but does not cure the disease.
11. Is pregnancy possible in Multiple Sclerosis?
Yes. Many women have successful pregnancies with appropriate neurological supervision.
12. Does exercise help?
Regular exercise improves fatigue, balance, muscle strength, and overall quality of life.
13. Is vitamin D supplementation useful?
Vitamin D deficiency should be corrected because adequate levels may support immune health.
14. What factors worsen prognosis?
Frequent relapses, delayed treatment, progressive disease, and significant spinal cord involvement.
15. Why is early diagnosis important?
Early initiation of disease-modifying therapy delays disability progression and improves long-term outcomes.
References
- McDonald Criteria for the Diagnosis of Multiple Sclerosis (2017 Revision).
- Harrison's Principles of Internal Medicine, 22nd Edition.
- Oxford Handbook of Neurology.
- Bradley's Neurology in Clinical Practice.
- Adams and Victor's Principles of Neurology.
- European Academy of Neurology Guidelines.
- American Academy of Neurology Practice Guidelines.
- National Multiple Sclerosis Society Clinical Resources.
Keywords
Multiple Sclerosis Quiz, Multiple Sclerosis MCQ, MS Clinical Case, Multiple Sclerosis Diagnosis, Multiple Sclerosis MRI, Optic Neuritis Quiz, Neurology MCQ, Internal Medicine Quiz, Demyelinating Disease, Relapsing Remitting MS, MS Management, MS Differential Diagnosis, MS Treatment, MS Clinical Pearls, Neurology Examination
Join Internal Medicine Quiz Community
Practice more Internal Medicine clinical quizzes, image-based cases, and exam-oriented discussions.
📘 Internal Medicine Quiz Facebook